Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase EARLY_PHASE1 7Phase NA 6Phase 3 5Phase 1 5Phase 4 4Phase 1/2 4

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Plasma cell 1

Conditions

Tuberous Sclerosis 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphangioleiomyomatosis 1Advanced Biliary Tract Carcinoma 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Simvastatin × Clear all
NCT07392541 2026-03-23

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Tongji Hospital

Phase 1/2 Recruiting
29 enrolled
Gastrointestinal

Advanced Biliary Tract Carcinoma

NCT06030622 2024-04-19

C3

State University of New York - Downstate Medical Center

Phase 1/2 Unknown
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed
10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00281476 2011-11-01

The Effect of High Dose Simvastatine on Multiple Myeloma

Vejle Hospital

Phase 1/2 Completed
10 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡